5[1]Yang Zhiwei,Zhang Xinglu,Strebel P,et al.The changing epidemiology of measles in China and the impact of the measles vaccination program.Unpublished manuscript.2000.
6[6]Centers for Disease Control and Prevention.Measles,mumps,and rubella-vaccine use and strategies for elimination of measles,rubella,and congenital rubella syndrome and control of mumps:Recommendations of the Advisory Committee on Immunization Practices(ACIP)[J].MMWR,1998,47(RR-8):1-57.
7[7]Markowitz LE,Preblud SR,Fine PE,et al.Duration of live measles vaccine-induced immunity[J].Pediatr Infect Dis J,1990,9:101-110.
8[8]Krugman S.Further-attenuated measles vaccine:characteristics and use[J].Rev Infect Dis,1983,5:477-481.
9[9]Markowitz LE,Albrecht P,Orenstein WA,et al.Persistence of measles antibody after revaccination[J].J Infect Dis,1992,166:205-208.
10[10]Mathias RG,Meekison WG,Arcand TA,et al.The role of secondary vaccine failures in measles outbreaks[J].Am J Public Health,1989,79:475-478.
